Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

HEALTHCARE GROUP DENMARK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   6.6% 6.2% 8.6% 9.0% 7.6% 6.5% 15.7% 15.7%   Credit score (0-100)   37 38 27 27 31 37 12 12   Credit rating   BBB BBB BB BB BB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   199 154 195 143 133 295 0.0 0.0   EBITDA   199 154 195 143 133 295 0.0 0.0   EBIT   199 142 183 131 120 295 0.0 0.0   Pre-tax profit (PTP)   193.7 136.8 175.5 121.8 108.0 281.2 0.0 0.0   Net earnings   148.5 105.1 132.5 93.7 83.4 217.2 0.0 0.0   Pre-tax profit without non-rec. items   194 137 176 122 108 281 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   0.0 36.7 24.5 12.2 0.0 0.0 0.0 0.0   Shareholders equity total   601 706 289 183 266 483 403 403   Interest-bearing liabilities   57.2 73.4 67.1 289 327 355 0.0 0.0   Balance sheet total (assets)   724 830 418 516 631 923 403 403   Net Debt   -523 -586 -187 -59.2 -148 -415 -403 -403     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   199 154 195 143 133 295 0.0 0.0   Gross profit growth   155.8% -22.8% 26.5% -26.5% -7.4% 122.4% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   724 830 418 516 631 923 403 403   Balance sheet change%   36.8% 14.6% -49.6% 23.4% 22.3% 46.2% -56.3% 0.0%   Added value   199.3 154.0 194.8 143.2 132.5 294.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 24 -24 -24 -24 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   100.0% 92.1% 93.7% 91.5% 90.8% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   31.8% 18.3% 29.3% 28.0% 21.0% 38.0% 0.0% 0.0%   ROI %   34.6% 19.7% 32.1% 31.5% 22.5% 41.3% 0.0% 0.0%   ROE %   28.2% 16.1% 26.6% 39.7% 37.2% 58.0% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   83.1% 85.2% 69.1% 35.4% 42.1% 52.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -262.4% -380.6% -96.0% -41.3% -111.6% -140.7% 0.0% 0.0%   Gearing %   9.5% 10.4% 23.2% 158.4% 122.8% 73.4% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   11.3% 7.5% 10.0% 5.1% 4.0% 4.2% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   5.6 6.1 2.7 1.4 1.6 2.0 0.0 0.0   Current Ratio   5.6 6.1 2.7 1.4 1.6 2.0 0.0 0.0   Cash and cash equivalent   580.2 659.4 254.2 348.6 474.6 769.2 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   561.5 629.8 224.6 133.3 226.2 443.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   199 154 195 143 133 295 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   199 154 195 143 133 295 0 0   EBIT / employee   199 142 183 131 120 295 0 0   Net earnings / employee   148 105 133 94 83 217 0 0